65,437 trials
Functional Abdominal Pain · Functional Dyspepsia · Irritable Bowel Syndrome
Primary: The Primary Outcome Measure Was Mean Daily Pain — 39.9; 45.14 pain scale by VAS in mm — p=<0.03
Pancreatic Adenocarcinoma · Resectable Pancreatic Carcinoma
Primary: Overall Survival (OS) — 23.2; 23.6 Months — p=.15
Hearing Loss, Conductive
Primary: Percentage of Correct Word Responses — 2.21; 0.1; 71.7; 87.9 percentage of correct word responses
Melanoma
Primary: Recurrence-free Survival (RFS) - All Randomized Participants — NA; NA Months
Lung Neoplasms · Lung Cancer
Primary: Radiation Safety (Rate of Grade 2 or Higher (Grade 2+) Radiation Pneumonitis as Defined by the Common Toxicity Criteria for Adverse Effects (CTCAE) Scoring System — 10…
Neck Injuries
Primary: Measurement of the Level of Discomfort Produced by the Spinal Collar in Adult Patients With a C-spine (Neck) Injury. — 1; 4.9 score on a scale
Blepharoptosis
Primary: Humphrey Visual Field — 9.8; 12.1; 11.1; 16.1 Points seen
Leukemia, Lymphocytic, Chronic, B-Cell
Primary: Overall Response Rate (ORR) — 33.3 percentage of participants
Healthy Volunteers
Primary: Part 1: Peak Maximum Plasma Concentration (Cmax) of Apremilast — 451; 459 ng/mL
Non-Small-Cell Lung Cancer
Primary: Objective Response Rate (ORR) by PD-L1 Positive and Negative Levels - Part 1 — 41.3; 14.9 Percentage of participants
Atherosclerosis
Primary: Coronary Artery Calcium (Serial Calcium Scans) — 26.3; 40.5 mm cubed
Type2 Diabetes Mellitus
Primary: Cmax (Maximum Observed Plasma Concentration) — 124.6; 135.5; 158.6; 143.7 ng/mL
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Primary: Percentage of Participants With Cytogenetic Response (Complete Cytogenetic Response and Major Cytogenetic Response) to STI571 — 29.6; 37.2; 45.8; 45.4 percentage of…
Philadelphia Positive Chronic Myeloid Leukemia · Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia
Primary: Percentage of Participants With Hematologic Response in Accelerated Phase Chronic Myeloid/Myelogenous Leukemia — 64.9; 74.7 percentage of participants
COPD Asthma
Primary: Total Number of Healthcare Visits — 111; 76; 119; 93 Participants